1
|
Barcan AS, Barcan RA, Vamanu E. Therapeutic Potential of Fungal Polysaccharides in Gut Microbiota Regulation: Implications for Diabetes, Neurodegeneration, and Oncology. J Fungi (Basel) 2024; 10:394. [PMID: 38921380 PMCID: PMC11204944 DOI: 10.3390/jof10060394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2024] [Revised: 05/04/2024] [Accepted: 05/22/2024] [Indexed: 06/27/2024] Open
Abstract
This review evaluates the therapeutic effects of polysaccharides derived from mushroom species that have medicinal and edible properties. The fungal polysaccharides were recently studied, focusing on their modulation of the gut microbiota and their impact on various diseases. The study covers both clinical and preclinical studies, detailing the results and highlighting the significant influence of these polysaccharides on gut microbiota modulation. It discusses the potential health benefits derived from incorporating these polysaccharides into the diet for managing chronic diseases such as diabetes, neurodegenerative disorders, and cancer. Furthermore, the review emphasizes the interaction between fungal polysaccharides and the gut microbiota, underscoring their role in modulating the gut microbial community. It presents a systematic analysis of the findings, demonstrating the substantial impact of fungal polysaccharides on gut microbiota composition and function, which may contribute to their therapeutic effects in various chronic conditions. We conclude that the modulation of the gut microbiota by these polysaccharides may play a crucial role in mediating their therapeutic effects, offering a promising avenue for further research and potential applications in disease prevention and treatment.
Collapse
Affiliation(s)
- Alexandru Stefan Barcan
- Faculty of Biotechnology, University of Agricultural Sciences and Veterinary Medicine, 011464 Bucharest, Romania
- School of Biodiversity, One Health & Veterinary Medicine, University of Glasgow, Graham Kerr Building, Glasgow G12 8QQ, UK
| | | | - Emanuel Vamanu
- Faculty of Biotechnology, University of Agricultural Sciences and Veterinary Medicine, 011464 Bucharest, Romania
| |
Collapse
|
2
|
Akhtar N, Wani AK, Sharma NR, Sanami S, Kaleem S, Machfud M, Purbiati T, Sugiono S, Djumali D, Retnaning Prahardini PE, Purwati RD, Supriadi K, Rahayu F. Microbial exopolysaccharides: Unveiling the pharmacological aspects for therapeutic advancements. Carbohydr Res 2024; 539:109118. [PMID: 38643705 DOI: 10.1016/j.carres.2024.109118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2023] [Revised: 04/15/2024] [Accepted: 04/15/2024] [Indexed: 04/23/2024]
Abstract
Microbial exopolysaccharides (EPSs) have emerged as a fascinating area of research in the field of pharmacology due to their diverse and potent biological activities. This review paper aims to provide a comprehensive overview of the pharmacological properties exhibited by EPSs, shedding light on their potential applications in various therapeutic areas. The review begins by introducing EPSs, exploring their various sources, significance in microbial growth and survival, and their applications across different industries. Subsequently, a thorough examination of the pharmaceutical properties of microbial EPSs unveils their antioxidant, immunomodulatory, antimicrobial, antidepressant, antidiabetic, antiviral, antihyperlipidemic, hepatoprotective, anti-inflammatory, and anticancer activities. Mechanistic insights into how different EPSs exert these therapeutic effects have also been discussed in this review. The review also provides comprehensive information about the monosaccharide composition, backbone, branches, glycosidic bonds, and molecular weight of pharmacologically active EPSs from various microbial sources. Furthermore, the factors that can affect the pharmacological activities of EPSs and approaches to improve the EPSs' pharmacological activity have also been discussed. In conclusion, this review illuminates the immense pharmaceutical promise of microbial EPS as versatile bioactive compounds with wide-ranging therapeutic applications. By elucidating their structural features, biological activities, and potential applications, this review aims to catalyze further research and development efforts in leveraging the pharmaceutical potential of microbial EPS for the advancement of human health and well-being, while also contributing to sustainable and environmentally friendly practices in the pharmaceutical industry.
Collapse
Affiliation(s)
- Nahid Akhtar
- School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, (144411), Punjab, India
| | - Atif Khurshid Wani
- School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, (144411), Punjab, India.
| | - Neeta Raj Sharma
- School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, (144411), Punjab, India
| | - Samira Sanami
- Health Promotion Research Center, Iran University of Medical Sciences, Tehran, Iran
| | - Shaikh Kaleem
- School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, (144411), Punjab, India
| | - Moch Machfud
- Research Center for Estate Crops, National Research and Innovation Agency, Bogor, (16911), Indonesia
| | - Titiek Purbiati
- Research Center for Horticulture, National Research and Innovation Agency, Bogor, (16911), Indonesia
| | - Sugiono Sugiono
- Research Center for Horticulture, National Research and Innovation Agency, Bogor, (16911), Indonesia
| | - Djumali Djumali
- Research Center for Estate Crops, National Research and Innovation Agency, Bogor, (16911), Indonesia
| | | | - Rully Dyah Purwati
- Research Center for Estate Crops, National Research and Innovation Agency, Bogor, (16911), Indonesia
| | - Khojin Supriadi
- Research Center for Food Crops, National Research and Innovation Agency, Bogor, (16911), Indonesia
| | - Farida Rahayu
- Research Center for Genetic Engineering, National Research and Innovation Agency, Bogor, (16911), Indonesia
| |
Collapse
|
3
|
Tian J, Zhang Z, Shang Y, Zheng Y. Extraction, structure and antioxidant activity of the polysaccharides from morels (Morchella spp.): A review. Int J Biol Macromol 2024; 264:130656. [PMID: 38453116 DOI: 10.1016/j.ijbiomac.2024.130656] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2023] [Revised: 01/28/2024] [Accepted: 03/04/2024] [Indexed: 03/09/2024]
Abstract
Morels (Morchella spp.), which are cultivated only in a few regions of the world, are edible mushrooms known for their various properties including antioxidation, immune regulation, antiinflammation, and antitumor effects. Polysaccharides from Morchella are principally responsible for its antioxidant activity. This paper reviews the extraction, purification, structural analysis and antioxidant activity of Morchella polysaccharides (MPs), providing updated research progress. Meanwhile, the structural-property relationships of MPs were further discussed. In addition, based on in vitro and in vivo studies, the major factors responsible for the antioxidant activity of MPs were summarized including scavenging free radicals, reduction capacity, inhibitory lipid peroxidation activity, regulating the signal transduction pathway, reducing the production of ROS and NO, etc. Finally, we hope that our research can provide a reference for further research and development of MPs.
Collapse
Affiliation(s)
- Jinfeng Tian
- College of Basic Medicine, Panzhihua University, Panzhihua 617000, PR China
| | - Zhe Zhang
- College of Biological and Chemical Engineering, Panzhihua University, Panzhihua 617000, PR China
| | - Yuanhong Shang
- College of Biological and Chemical Engineering, Panzhihua University, Panzhihua 617000, PR China.
| | - Yi Zheng
- College of Biological and Chemical Engineering, Panzhihua University, Panzhihua 617000, PR China
| |
Collapse
|
4
|
Badalyan SM, Gharibyan NG, Iotti M, Zambonelli A. Antimicrobial Activity of Three Italian Strains of Morchella esculenta (Ascomycota). Int J Med Mushrooms 2024; 26:43-55. [PMID: 38421695 DOI: 10.1615/intjmedmushrooms.2023051956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/02/2024]
Abstract
Three genetically identified and morphologically characterized strains (MesAQ2-C, MesAQ6-2 and MesFI2-3) of the culinary-medicinal ascomycete mushroom Morchella esculenta (L.) Pers. collected in central-north Italy have been studied for their antifungal and antibacterial activities. The obtained data showed that mycelium of M. esculenta possess variable antimicrobial activity against four test fungi (Chrysosporium keratinophilum, Microsporum gypseum, Trichophyton terrestre, Penicillium griseofulvum), as well as one Gram positive (Staphylococcus aureus) and three Gram negative (Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa) test bacteria potentially pathogenic for humans and animals. Up to 20.4% of inhibition of the average mycelial growth rate (GRavr) of test fungi in dual culture experiment was detected. The samples of cultural liquid (CL) and mycelial extract (ME) obtained by static cultivation of M. esculenta strains showed up to 13.9 and 23.0% of GRavr inhibition of test fungi, respectively. Similarly, the inhibition of the bacterial colonies by CL and ME samples was 34.1 and 32.3%, respectively in comparison with the control with streptomycin indicating almost equal secretion of both intra- and extracellular antimicrobial compounds by M. esculenta mycelium. As a producer of antimicrobial compounds among tested M. esculenta strains, MesAQ2-C was the most effective. It may be considered for further myco-pharmacological research to develop mushroom-based antimicrobial biotech products with biomedical significance.
Collapse
Affiliation(s)
- Susanna M Badalyan
- Laboratory of Fungal Biology and Biotechnology, Institute of Pharmacy, Yerevan State University, 1 A. Manoogian St., 0025 Yerevan, Armenia
| | - Narine G Gharibyan
- Laboratory of Fungal Biology and Biotechnology, Institute of Pharmacy, Yerevan State University, Yerevan, Armenia
| | - Mirco Iotti
- Department of Life, Health and Environmental Science, University of L'Aquila, L'Aquila, Italy
| | | |
Collapse
|
5
|
Li Y, Chen H, Zhang X. Cultivation, nutritional value, bioactive compounds of morels, and their health benefits: A systematic review. Front Nutr 2023; 10:1159029. [PMID: 37006947 PMCID: PMC10063854 DOI: 10.3389/fnut.2023.1159029] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2023] [Accepted: 02/27/2023] [Indexed: 03/19/2023] Open
Abstract
Morels are valuable mushrooms being used as foods and medical substances for a long history. The commonly cultivated morel species include M. eximia, M. importuna, and M. sextelata in China, M. conica and M. esculenta in the US. Morels' nutritional profile mainly consists of carbohydrates, proteins, fatty acids, vitamins, minerals, and organic acids, which are also responsible for its complex sensory attributes and health benefits. The bioactive compounds in morels including polysaccharides, phenolics, tocopherols, and ergosterols contribute to the anti-oxidative abilities, anti-inflammation, immunoprotection, gut health preservation, and anti-cancer abilities. This review depicted on the cultivation of morels, major bioactive compounds of different morel species both from fruit bodies and mycelia, and their health benefits to provide a comprehensive understanding of morels and support the future research and applications of morels as high-value functional food sources.
Collapse
Affiliation(s)
- Yitong Li
- Bannerbio Nutraceuticals Inc., Shenzhen, China
| | - Hongyu Chen
- National Engineering Research Center of Edible Fungi, Key Laboratory of Applied Mycological Resources and Utilization of Ministry of Agriculture, Institute of Edible Fungi, Shanghai Academy of Agricultural Sciences, Shanghai, China
| | - Xi Zhang
- Bannerbio Nutraceuticals Inc., Shenzhen, China
- *Correspondence: Xi Zhang
| |
Collapse
|